NCT04762992: LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)
- State
- Under way
- Phase
- Phase 3
- People
- 12 planned
- Started
- 18 Jul 2022
- Primary completion
- 30 Jul 2026
- Arms
- Intervention group, enoxaparin
- Results
- None posted
- 21 Feb 2021: Trial registered
- 18 Jul 2022: Trial started